Trial intelligence / Profile preview

Comparison of the analgesic effect of oxycodone, diclofenac, gabapentin in tibial fracture

IRCT20230716058804N1Phase 3Completed

Sponsor
Directorate of Health, Rescue and Treatment of the Police Headquarters
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of oxycodone, diclofenac and gabapentin in tibia fracture (3 arms), sponsored by Directorate of Health, Rescue and Treatment of the Police Headquarters. Started Aug 2023; status: completed.

02

Drugs

oxycodonediclofenacgabapentin
03

Conditions

tibia fracture

Beyond the preview

Go deeper on IRCT20230716058804N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230716058804N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call